Key Financial Data Of Group

Sumitomo Pharma Co., Ltd. - Filing #7303560

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of group
Business results of group
Revenue
180,749,000,000 JPY
314,558,000,000 JPY
152,642,000,000 JPY
Profit (loss) before tax
-32,406,000,000 JPY
-323,114,000,000 JPY
-56,127,000,000 JPY
Profit (loss), attributable to owners of parent
-32,229,000,000 JPY
-314,969,000,000 JPY
-67,741,000,000 JPY
Comprehensive income, attributable to owners of parent
-41,893,000,000 JPY
-250,385,000,000 JPY
8,039,000,000 JPY
Equity attributable to owners of parent
114,170,000,000 JPY
156,063,000,000 JPY
412,007,000,000 JPY
Total assets
799,765,000,000 JPY
907,506,000,000 JPY
1,148,855,000,000 JPY
Basic earnings (loss) per share
-81.12
-792.79
-170.51
Diluted earnings (loss) per share
Ratio of owners' equity to gross assets
0.143 xbrli:pure
0.172 xbrli:pure
0.359 xbrli:pure
Cash flows from (used in) operating activities
4,552,000,000 JPY
-241,893,000,000 JPY
-174,497,000,000 JPY
Cash flows from (used in) investing activities
97,451,000,000 JPY
33,036,000,000 JPY
32,675,000,000 JPY
Cash flows from (used in) financing activities
-29,436,000,000 JPY
77,851,000,000 JPY
44,797,000,000 JPY
Cash and cash equivalents
99,082,000,000 JPY
29,047,000,000 JPY
60,397,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.